CA
VRX

Cullinan Associates’s VALEANT PHARMACEUTICALS INTL VRX Stock Holding History

Cullinan Associates’s Portfolio VRX Stock Details VRX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-46,500
Closed -$1.08M – 183
2018
Q2 		$1.08M Buy
46,500
+500
+1% +$11.6K 0.08% 124
2018
Q1 		$732K Buy
46,000
+1,000
+2% +$15.9K 0.06% 143
2017
Q4 		$935K Buy
+45,000
New +$935K 0.07% 133